Objective To our knowledge, there is no broad genomic analysis comparing skin and
synovium in psoriatic arthritis (PsA). Also, there is little understanding of the relative levels of …

Psoriasis is a skin disease where various cytokines play a detrimental role, yet our
understanding of the disease is still limited. TNF is a validated drug target in psoriasis and …

Psoriasis is a common chronic inflammatory skin disease, associated with substantial
comorbidity. TH17 lymphocytes, differentiating under the influence of dendritic cell-derived …

Background Psoriasis is a chronic, systemic immune‐mediated disease characterized by
development of erythematous, indurated, scaly, pruritic and often painful skin plaques …

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to
decreased health-related quality of life and permanent joint damage leading to functional …

Objective To examine the association of biologic therapy use for psoriasis with incident
psoriatic arthritis (PsA) diagnosis. Methods A retrospective cohort study was conducted in …

Psoriasis is a chronic systemic inflammatory disease causing erythematosus and scaly skin
plaques; up to 30% of patients with psoriasis develop Psoriatic Arthritis (PsA), which is …

Since the foundation of the European Society for Dermatological Research, pathogenesis of
psoriasis has been studied by many research groups, focusing on various compartments of …

Psoriasis is a frequent, chronic disease characterized by cutaneous inflammatory plaques
and/or arthritis. It may be associated with few other diseases, mainly Crohn's disease and …

Psoriasis is a complex inflammatory process resulting from activation of the well-defined
interleukin (IL)-23/T17 cytokine axis. We review the role of key cytokines IL-17 and IL-23 in …